Providers Can Now Efficiently Assess and Manage Cholesterol for Their Adult Patients
Cholesterol Facts
One in three American adults have high levels of LDL-cholesterol, a major contributor to atherosclerotic cardiovascular disease (ASCVD).
$251.4 billion
Annual direct cost of ASCVD in the US 1
<50%
Of patients with ASCVD have a prescription for a statin 2
25.5%
Prevalence of statin use for primary prevention 3
Latest Guidelines
The latest American College of Cardiology (ACC)/American Heart Association (AHA) Guideline on the Management of Blood Cholesterol (2018) is the most comprehensive guideline ever released.
120
Page guideline
77
Unique patients factors
35
Treatment endpoints
MedsEngine Cholesterol applies the guidelines in seconds and provides real-time personalized treatment recommendations.
Simple Steps to Assess and Manage Cholesterol in Seconds
Step 1: Initiate Assessment
Action
After the provider launches MedsEngine from their EHR, a snapshot of relevant laboratory results and metrics are displayed for all available diseases. “Cholesterol” is selected from the list of chronic diseases to assess that day.
Outcome
MedsEngine retrieves 77 clinical factors necessary to determine guideline recommendations and displays them on the Validation page for verification.
Step 2: Determine Type of Prevention
Action
The provider reviews and verifies the retrieved data from the EHR to determine primary or secondary prevention and if the patient has Diabetes.
Outcome
MedsEngine analyzes the verified data to generate and display the guideline determined type of prevention the patient requires.
Step 3: Verify Cholesterol Factors
Action
The provider quickly reviews and confirms the accuracy of the patient’s clinical data.
Outcome
MedsEngine analyzes the verified data to display the patient's LDL-C history, clinical factors, risk level, and LDL-C goal. Medication and dose recommendations are displayed.
Step 4: Review the Risk
Action
The provider reviews the displayed information with the patient.
Outcome
The patient can clearly see the numerous factors involved in their ASCVD prevention care.
Step 5: Choose Medications
Action
The provider reviews the recommendations and chooses to prescribe medication according to the patient's cardiovascular risk. Timely follow-up recommendations are provided to assess tolerance and encourage rapid attainment of goals.
Outcome
MedsEngine empowers the provider to confidently manage cholesterol according to the most recent clinical guidelines. Appropriate control reduces the risk of stroke, coronary artery disease, and heart failure.
Step 6: Enhance Patient Understanding and Adherence
Action
A comprehensive cholesterol patient summary report is generated and printed.
Outcome
The report includes personalized education to bolster patient understanding and adherence to the prescribed treatment.
Value-Added Features
10-Year ASCVD Risk Calculator
Embedded and only displays when appropriate per the guidelines. Pertinent data from the EHR automatically populates the calculator.
Coronary Calcium Score
Advised for consideration when guidelines determine it could change recommendations.
Proven Results
Patient Metrics from a 23-Provider Primary Care Group using MedsEngine Cholesterol
14,410
Patients evaluated in 6 months
45%
Patients with specific
LDL-cholesterol goal
62%
Patients with a recommendation to be on a Statin
1 https://professional.heart.org/en/science-news/heart-disease-and-stroke-statistics-2023-update
2 Klimchak AC, Patel MY, Iorga ŞR, Kulkarni N, Wong ND. Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States. Am J Prev Cardiol. 2020 May 1;1:100010. doi: 10.1016/j.ajpc.2020.100010. Erratum in: Am J Prev Cardiol. 2021 Mar 29;5:100160. PMID: 34327452; PMCID: PMC8315384.
3 Jacobs JA, Addo DK, Zheutlin AR, et al. Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020. JAMA Cardiol. 2023;8(5):443–452. doi:10.1001/jamacardio.2023.0228
Contact us to learn more about what MedsEngine can do for you.
